SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 490 filers reported holding SEATTLE GENETICS INC in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $7,052,000 | +84.7% | 41,500 | +25.4% | 0.20% | +47.5% |
| Q1 2020 | $3,819,000 | +64.7% | 33,100 | +63.1% | 0.14% | +110.6% |
| Q4 2019 | $2,319,000 | +92.6% | 20,300 | +44.0% | 0.07% | +83.3% |
| Q3 2019 | $1,204,000 | +12.9% | 14,100 | -8.4% | 0.04% | +16.1% |
| Q2 2019 | $1,066,000 | +6.3% | 15,400 | +12.4% | 0.03% | +6.9% |
| Q1 2019 | $1,003,000 | +120.4% | 13,700 | +132.2% | 0.03% | +141.7% |
| Q3 2018 | $455,000 | -52.3% | 5,900 | -67.6% | 0.01% | -52.0% |
| Q1 2018 | $953,000 | +335.2% | 18,200 | +343.9% | 0.02% | +400.0% |
| Q4 2017 | $219,000 | -1.8% | 4,100 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $223,000 | +5.2% | 4,100 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $212,000 | – | 4,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |